These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32156290)

  • 1. Identification of key differentially expressed genes and gene mutations in breast ductal carcinoma in situ using RNA-seq analysis.
    Zhu C; Hu H; Li J; Wang J; Wang K; Sun J
    World J Surg Oncol; 2020 Mar; 18(1):52. PubMed ID: 32156290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-Seq of human breast ductal carcinoma in situ models reveals aldehyde dehydrogenase isoform 5A1 as a novel potential target.
    Kaur H; Mao S; Li Q; Sameni M; Krawetz SA; Sloane BF; Mattingly RR
    PLoS One; 2012; 7(12):e50249. PubMed ID: 23236365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.
    Ropri AS; DeVaux RS; Eng J; Chittur SV; Herschkowitz JI
    Breast Cancer Res; 2021 Oct; 23(1):101. PubMed ID: 34717732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential key genes and high-frequency mutant genes in prostate cancer by using RNA-Seq data.
    Zhang Z; Wu H; Zhou H; Gu Y; Bai Y; Yu S; An R; Qi J
    Oncol Lett; 2018 Apr; 15(4):4550-4556. PubMed ID: 29616087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the breast ductal carcinoma in situ signature and its prognostic implications.
    Zhang J; Lin H; Hou L; Xiao H; Gong X; Guo X; Cao X; Liu Z
    Cancer Med; 2023 Feb; 12(3):3758-3772. PubMed ID: 35880695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of gene expression in ductal carcinoma in situ of the breast.
    Adeyinka A; Emberley E; Niu Y; Snell L; Murphy LC; Sowter H; Wykoff CC; Harris AL; Watson PH
    Clin Cancer Res; 2002 Dec; 8(12):3788-95. PubMed ID: 12473591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
    Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
    BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.
    Bao Y; Wang L; Shi L; Yun F; Liu X; Chen Y; Chen C; Ren Y; Jia Y
    Cell Mol Biol Lett; 2019; 24():38. PubMed ID: 31182966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
    Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
    Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
    Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
    Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
    Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
    Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer.
    Rossetti S; Bshara W; Reiners JA; Corlazzoli F; Miller A; Sacchi N
    Cancer Lett; 2016 Oct; 380(2):375-383. PubMed ID: 27422542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation.
    Shah S; Brock EJ; Jackson RM; Ji K; Boerner JL; Sloane BF; Mattingly RR
    Neoplasia; 2018 Sep; 20(9):951-963. PubMed ID: 30144784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.
    Bergholtz H; Kumar S; Wärnberg F; Lüders T; Kristensen V; Sørlie T
    Cancer Rep (Hoboken); 2020 Jun; 3(3):e1248. PubMed ID: 32671987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
    Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
    Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.
    Abba MC; Gong T; Lu Y; Lee J; Zhong Y; Lacunza E; Butti M; Takata Y; Gaddis S; Shen J; Estecio MR; Sahin AA; Aldaz CM
    Cancer Res; 2015 Sep; 75(18):3980-90. PubMed ID: 26249178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma
    Shan NL; Minden A; Furmanski P; Bak MJ; Cai L; Wernyj R; Sargsyan D; Cheng D; Wu R; Kuo HD; Li SN; Fang M; Maehr H; Kong AN; Suh N
    Cancer Prev Res (Phila); 2020 Aug; 13(8):673-686. PubMed ID: 32467291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
    Scribner KC; Behbod F; Porter WW
    Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of loss of heterozygosity and expression profile in normal tissue, DCIS and invasive breast cancer.
    Zikan M; Bohm J; Pavlista D; Cibula D
    Clin Transl Oncol; 2011 Sep; 13(9):652-5. PubMed ID: 21865136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.